%0 Journal Article
%T Protein Induced by Vitamin K Absence II (PIVKA-II) as a potential serological biomarker in pancreatic cancer: a pilot study
%A Anastasi
%A Emanuela
%A Angeloni
%A Antonio
%A Granato
%A Teresa
%A Manganaro
%A Lucia
%A Marchese
%A Cinzia
%A Pecorella
%A Irene
%A Tartaglione
%A Sara
%A Viggiani
%A Valentina
%A Zarrillo
%A Serena Rita
%J -
%D 2019
%R 10.11613/BM.2019.020707
%X Saˋetak Introduction: Protein induced by vitamin K absence II (PIVKA-II) is an abnormal prothrombin increased in gastrointestinal malignancy. We aimed to evaluate PIVKA-II in comparison to established pancreatic cancer (PC) biomarkers (CA 19-9, carcinoembryonic antigen (CEA) and CA 242) measured in PC patients and in patients with benign pancreatic diseases. Materials and methods: We studied 26 PC patients (Group 1) and 20 patients with benign pancreatic diseases (Group 2). PIVKA-II and CEA were measured by chemiluminescent enzyme immunoassay method (CLEIA) on LUMIPULSE G1200 (Fujirebio-Europe, Gent, Belgium), CA 19-9 and CA 242 were measured by ELSA (CisBio Bioassays, Codolet, France) and EIA (Fujirebio Diagnostics AB, Gˋteborg, Sweden), respectively. Receiver operating characteristic (ROC) analysis was performed to assess biomarkers＊ diagnostic characteristics in both groups. Results: Median and interquartile range (IQR) in Group 1 and Group 2 were: 1749.0 (320.2 每 3921.0) vs. 31.0 (23.0 每 43.0) mAU/mL (P < 0.001) for PIVKA-II, 260.0 (158.7 每 272.0) vs. 45.2 (9.0 每 58.0) U/mL (P = 0.034) for CA 19-9, 104.0 (30.2 每 150.0) vs. 7.2 (4.8 每 26.0) U/mL (P < 0.050) for CA 242, 9.4 (5.3 每 37.5) vs. 4.5 (1.8 每 7.0) ng/mL (P = 0.021) for CEA. Areas under the ROC curve of PIVKA-II, CA 19-9, CA 242, CEA were 0.86 (95% CI: 0.71 每 1.00), 0.58 (95% CI: 0.38 每 0.78), 0.73 (95% CI: 0.54 每 0.92), 0.64 (95% CI: 0.44 每 0.85), respectively. Conclusions: PIVKA-II is significantly higher in PC than in benign pancreatic diseases. PIVKA-II shows a rather good diagnostic performance compared to CA 19-9, CEA and CA242, thus its determination could help PC management
%K pancreatic cancer
%K PIVKA-II
%K CA 19-9
%K CA 242
%K CEA
%U https://hrcak.srce.hr/index.php?show=clanak&id_clanak_jezik=322742